Cargando…

Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer

Limited information on salvage treatment in patients affected by pancreatic cancer is available. At failure, about half of the patients present good performance status (PS) and are candidate for further treatment. Patients >18 years, PS ⩾50, with metastatic pancreatic adenocarcinoma previously tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reni, M, Pasetto, L, Aprile, G, Cordio, S, Bonetto, E, Dell'oro, S, Passoni, P, Piemonti, L, Fugazza, C, Luppi, G, Milandri, C, Nicoletti, R, Zerbi, A, Balzano, G, Di Carlo, V, Brandes, A A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361378/ https://www.ncbi.nlm.nih.gov/pubmed/16508631 http://dx.doi.org/10.1038/sj.bjc.6603026

Ejemplares similares

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma
por: Ulrich-Pur, H, et al.
Publicado: (2003)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2016)

A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma
por: Arends, J J, et al.
Publicado: (2005)

Response to: Comment on: Pancreatectomy With Islet-Autotransplantation as Alternative for Pancreato-Duodenectomy in Patients With a High-Risk for Postoperative Pancreatic Fistula: The Jury Is Still Out
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Comment on Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-Risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer
por: Feliu, J, et al.
Publicado: (2005)

New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').
por: Blackledge, G.
Publicado: (1998)

Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles for Colorectal Cancer Theranostics
por: Rosch, Justin G., et al.
Publicado: (2020)

Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients
por: Comella, P, et al.
Publicado: (2002)

Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma
por: Ford, H E R, et al.
Publicado: (2000)

Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer.
por: Woll, P. J., et al.
Publicado: (1997)

Preliminary investigation of intraperitoneal raltitrexed in patients with gastric cancer
por: Zhao, Ping, et al.
Publicado: (2014)

Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma
por: Österlund, P, et al.
Publicado: (2002)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
por: Ferrara, Benedetta, et al.
Publicado: (2022)

Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).
por: Judson, I., et al.
Publicado: (1998)

Mature results from three large controlled studies with raltitrexed ('Toxudex')
Publicado: (1998)

Mature results from three large controlled studies with raltitrexed ('Tomudex').
por: Cunningham, D.
Publicado: (1998)

Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
por: Ferreri, A J M, et al.
Publicado: (2004)

Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.
por: KÃ¶hne, C. H., et al.
Publicado: (1998)

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer
por: Huang, Mingzhu, et al.
Publicado: (2021)

Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
por: Guo, Jian-Hai, et al.
Publicado: (2017)

Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4
por: Hu, Cong, et al.
Publicado: (2022)

A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma
por: Eatock, M M, et al.
Publicado: (2000)

Schedule‐dependent Interactions between Raltitrexed and Cisplatin in Human Carcinoma Cell Lines in vitro
por: Kano, Yasuhiko, et al.
Publicado: (2000)

S‐1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial
por: Chen, Ye, et al.
Publicado: (2019)

Clinical efficacy of irinotecan plus raltitrexed chemotherapy in refractory esophageal squamous cell cancer
por: Liu, Min, et al.
Publicado: (2020)

Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study
por: Feliu, J, et al.
Publicado: (2004)

Structural Analysis of Thymidylate Synthase from Kaposi’s Sarcoma-Associated Herpesvirus with the Anticancer Drug Raltitrexed
por: Choi, Yong Mi, et al.
Publicado: (2016)

Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
por: Shao, Wenbo, et al.
Publicado: (2019)

Raltitrexed as a synergistic hyperthermia chemotherapy drug screened in patient-derived colorectal cancer organoids
por: Zeng, Lisi, et al.
Publicado: (2021)

Raltitrexed as a substitute for capecitabine in metastatic gastric cancer: a case report and literature review
por: Ladak, Imran, et al.
Publicado: (2022)

Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
por: Liu, Xiu, et al.
Publicado: (2023)

Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: Ferrara, Deborah, et al.
Publicado: (2018)

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer
por: D'Agostino, G, et al.
Publicado: (2003)

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis
por: Zhen, Hongchao, et al.
Publicado: (2023)

Clinical Limitations of Photon, Proton and Carbon Ion Therapy for Pancreatic Cancer
por: Dell’Oro, Mikaela, et al.
Publicado: (2020)

Schedule‐dependent Synergism and Antagonism between Raltitrexed (“Tomudex”) and Methotrexate in Human Colon Cancer Cell Lines in vitro
por: Kano, Yasuhiko, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_v0nk8cnatm2g69uu3tmkkgl30f